Home Dyax Corp. Stock Rating Upgraded by Vetr Inc.
 

Keywords :   


Dyax Corp. Stock Rating Upgraded by Vetr Inc.

2015-06-07 01:23:38| Biotech - Topix.net

The firm currently has a $25.05 target price on the biopharmaceutical company's stock. Vetr 's price objective points to a potential downside of 1.65% from the stock's previous close.

Tags: inc rating stock corp

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »